Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIACINAMIDE Cause Peripheral venous disease? 169 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 169 reports of Peripheral venous disease have been filed in association with NIACINAMIDE (PUVIDA SNOW BLEACH). This represents 13.2% of all adverse event reports for NIACINAMIDE.

169
Reports of Peripheral venous disease with NIACINAMIDE
13.2%
of all NIACINAMIDE reports
169
Deaths
168
Hospitalizations

How Dangerous Is Peripheral venous disease From NIACINAMIDE?

Of the 169 reports, 169 (100.0%) resulted in death, 168 (99.4%) required hospitalization, and 168 (99.4%) were considered life-threatening.

Is Peripheral venous disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIACINAMIDE. However, 169 reports have been filed with the FAERS database.

What Other Side Effects Does NIACINAMIDE Cause?

Off label use (540) Drug ineffective (436) Pain (405) Nausea (380) Infusion related reaction (325) Malaise (324) Gastrooesophageal reflux disease (311) Dyspepsia (310) Headache (283) Condition aggravated (256)

What Other Drugs Cause Peripheral venous disease?

RITUXIMAB (1,281) ADALIMUMAB (1,249) METHOTREXATE (1,246) SECUKINUMAB (1,186) ABATACEPT (1,168) DICLOFENAC (1,168) LEFLUNOMIDE (1,154) TOCILIZUMAB (1,137) PREDNISONE (1,101) ALENDRONATE (1,097)

Which NIACINAMIDE Alternatives Have Lower Peripheral venous disease Risk?

NIACINAMIDE vs NICARDIPINE NIACINAMIDE vs NICORANDIL NIACINAMIDE vs NICORETTE OTC NIACINAMIDE vs NICORETTE OTC, UNSPECIFIED NIACINAMIDE vs NICOTINE

Related Pages

NIACINAMIDE Full Profile All Peripheral venous disease Reports All Drugs Causing Peripheral venous disease NIACINAMIDE Demographics